Can We Defeat Meningococcal Disease in Low and Middle Income Countries?
This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological information to allow for rational decisions about vaccine introduction, and that enhanced surveillance is needed. They also assert that financial challenges predominate in middle-income countries, which could be addressed by demonstrating the cost-effectiveness of new meningococcal vaccines and through the introduction of a tiered-pricing system. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.).
Author(s): Greenwood B, Chiarot E, MacLennan CA, O'Ryan M
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Greenwood B, Chiarot E, MacLennan CA, O'Ryan M. Can We Defeat Meningococcal Disease in Low and Middle Income Countries? Vaccine. 2012;30(S2):B63-B66.